M
Merus NV D
D
MRUS
43.080
USD
3.41
(8.60%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-13
حجم السوق
2,976,417,405
العنوان: Merus NV
القطاع: Healthcare
الصناعة: Biotechnology
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.